(Q24244706)

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The present status and future potential of radiotherapy in the management of esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. A randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The role of intraluminal radiotherapy and concurrent 5-fluorouracil infusion in the management of carcinoma esophagus: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

National Cancer Data Base report on esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Multimodal treatment for squamous cell esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

1 reference

7 January 2021

The recording of morbidity related to radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study: the second Scandinavian trial in esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Incorporating variations in the quality of individual randomized trials into meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation--early termination of a prospective randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Mucosal regeneration during radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Chemotherapy and chemoradiotherapy for esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Oesophageal cancer treatment: studies, strategies and facts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Multimodal therapy for squamous carcinoma of the oesophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Safety and efficacy of concurrent cisplatin and radiotherapy in inoperable or metastatic squamous cell esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

High dose external beam radiation therapy with or without concomitant chemotherapy for esophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Multimodality therapy of esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus--a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Combined modality therapy for oesophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Combined treatment modalities in esophageal cancer. Should chemotherapy be included?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Meta-analysis in clinical research

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002092.PUB2

7 January 2021